Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-11-15 Option Award | 2024-11-18 2:08 pm | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Wong Vivien Director | 15,145 | $0 | 39,713 (Direct) | View |
2024-08-16 Option Award | 2024-08-20 1:49 pm | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Wong Vivien Director | 7,937 | $0 | 24,568 (Direct) | View |
2024-06-03 Option Award | 2024-06-05 5:08 pm | N/A 2034-06-03 | Cyclo Therapeutics Inc. | CYTH | Wong Vivien Director | 23,375 | $0 | 32,193 (Direct) | View |
2024-02-13 Option Award | 2024-02-15 4:42 pm | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Wong Vivien Director | 6,330 | $0 | 8,818 (Direct) | View |
2023-11-28 Option Award | 2023-11-30 09:06 am | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Wong Vivien Director | 2,488 | $0 | 2,488 (Direct) | View |
2023-08-17 Option Award | 2023-08-21 08:00 am | 2023-08-17 2033-08-17 | Cyclo Therapeutics Inc. | CYTH | Wong Vivien Director | 6,700 | $0 | 6,700 (Direct) | View |
Ownership | 2023-08-21 08:00 am | N/A N/A | Cyclo Therapeutics Inc. | CYTH | Wong Vivien Director | 0 | $0 | 0 (Direct) | View |
2020-06-19 Disposition | 2020-06-23 4:48 pm | N/A 2020-06-30 | PROGENICS PHARMACEUTICALS INC | PGNX | Wong Vivien EVP, Development | 809,760 | $0 | 0 (Direct) | View |
2020-03-02 Option Award | 2020-03-04 4:15 pm | N/A 2030-03-02 | PROGENICS PHARMACEUTICALS INC | PGNX | Wong Vivien EVP, Development | 82,214 | $0 | 82,214 (Direct) | View |